Related content

Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 93-108

Bentham Science Publishers

Access to resources Recommend Favorite

Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment

By Koyama Tomoki   Nimura Hiroshi   Kobayashi Katsutoshi   Marushima Hideki   Odaira Hironori   Kashimura Hirotaka   Mitsumori Norio   Yanaga Katsuhiko  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 235-239

Springer Publishing Company

Access to resources Recommend Favorite

Serum Midkine Correlates with Tumor Progression and Imatinib Response in Gastrointestinal Stromal Tumors

By Rawnaq Tamina  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 559-565

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

By Tonyali Onder   Coskun Ugur   Yildiz Ramazan   Karakan Tarkan   Demirci Umut   Akyurek Nalan   Benekli Mustafa   Buyukberber Suleyman  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 768-773

Humana Press, Inc

Access to resources Recommend Favorite

Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib

By Andtbacka Robert   Ng Chaan   Scaife Courtney   Cormier Janice   Hunt Kelly   Pisters Peter   Pollock Raphael   Benjamin Robert   Burgess Michael   Chen Lei   Trent Jonathan   Patel Shreyaskumar   Raymond Kevin   Feig Barry  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 14-24

Springer Publishing Company

Access to resources Recommend Favorite